Creative Planning
GMAB icon

Creative Planning’s Genmab GMAB Stock Holding History

Creative Planning’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.18M Sell
118,596
-11,987
-9% -$359K ﹤0.01% 1530
2025
Q4 		$4.02M Buy
130,583
+14,734
+13% +$459K ﹤0.01% 1165
2025
Q3 		$3.55M Buy
115,849
+50,717
+78% +$1.24M ﹤0.01% 1089
2025
Q2 		$1.35M Buy
65,132
+6,870
+12% +$141K ﹤0.01% 1621
2025
Q1 		$1.14M Sell
58,262
-48,566
-45% -$1.02M ﹤0.01% 1624
2024
Q4 		$2.23M Buy
106,828
+59,406
+125% +$1.31M ﹤0.01% 1064
2024
Q3 		$1.16M Buy
47,422
+27,353
+136% +$731K ﹤0.01% 1414
2024
Q2 		$504K Sell
20,069
-16,761
-46% -$475K ﹤0.01% 1936
2024
Q1 		$1.1M Buy
36,830
+14,088
+62% +$414K ﹤0.01% 1276
2023
Q4 		$724K Sell
22,742
-3,437
-13% -$108K ﹤0.01% 1449
2023
Q3 		$923K Buy
26,179
+6,281
+32% +$239K ﹤0.01% 1197
2023
Q2 		$756K Buy
19,898
+2,993
+18% +$119K ﹤0.01% 1285
2023
Q1 		$638K Buy
16,905
+1,868
+12% +$71.8K ﹤0.01% 1329
2022
Q4 		$637K Buy
15,037
+2,733
+22% +$113K ﹤0.01% 1292
2022
Q3 		$395K Buy
+12,304
New +$432K ﹤0.01% 1478
2021
Q1 		– Sell
-5,122
Closed -$208K – 2644
2020
Q4 		$208K Sell
5,122
-46,813
-90% -$1.75M ﹤0.01% 1876
2020
Q3 		$1.9M Buy
51,935
+224
+0.4% +$8.1K 0.01% 585
2020
Q2 		$1.75M Buy
+51,711
New +$1.41M 0.01% 545

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Creative Planning's GMAB Position: Q1 2026 in Review

Creative Planning reduced its Genmab (GMAB) stake by 9.2% in Q1 2026, selling an estimated $359K and leaving 118,596 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Creative Planning first reported a position in GMAB in Q2 2020 and has held it in 18 quarters since. The position peaked at $4.02M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Creative Planning held 118,596 shares of Genmab worth $3.18M as of Q1 2026.
  • Creative Planning sold 11,987 Genmab shares in Q1 2026, an estimated $359K.
  • Genmab made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1530 holding.
  • Creative Planning first reported a position in Genmab in Q2 2020 and has held it in 18 quarters since.
  • Creative Planning's Genmab position peaked at $4.02M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.